Portfolio company
Redwood Bioscience
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops protein-chemical engineering technology for producing antibody-drug conjugates and semi-synthetic biotherapeutics for pharmaceutical and biotechnology researchers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Catena Bio
This biotechnology firm develops protein conjugation technology and multi-payload therapeutic conjugates for biopharmaceutical companies to treat oncology and autoimmune diseases.
EnzyTag
This company develops and provides chemo-enzymatic peptide ligation technology and enzymes for pharmaceutical manufacturers to produce complex peptides and antibody-drug conjugates.
Hummingbird Bioscience
This company develops antibody-based therapeutics and drug conjugates for patients with hard-to-treat cancers and autoimmune diseases.
Silicozyme
This company develops enzymatic toolkits and bioprocessing technologies for protein manufacturing and biologics production for industrial biotechnology and pharmaceutical customers.
Glyphic Biotechnologies
This company develops a single-molecule protein sequencing platform for researchers and institutions focused on biological research and drug discovery.
Pinot Bio
The company develops antibody-drug conjugate platforms and targeted anticancer therapeutics for pharmaceutical firms and clinical-stage biotechnology partners.
Tierra Biosciences
This company provides custom synthetic proteins through an AI-guided cell-free platform for pharmaceutical, industrial and agricultural researchers to accelerate bio-based product discovery.
Think Bioscience
This company develops small-molecule therapeutics for pharmaceutical researchers by using synthetic biology and engineered microbes to target difficult-to-drug proteins.
